Hikma Pharmaceuticals PLC
SWB:H5P
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hikma Pharmaceuticals PLC
SWB:H5P
|
UK |
|
Centaurus Metals Ltd
OTC:CTTZF
|
AU |
|
G
|
Gen Digital Inc
SWB:SYM
|
US |
|
L
|
Lifedrink Company Inc
TSE:2585
|
JP |
|
S
|
Sixt SE
DUS:SIX3
|
DE |
|
Websolute SpA
MIL:WBS
|
IT |
|
B
|
Budapesti Ingatlan Hasznositasi es Fejlesztesi Nyrt
BET:BIF
|
HU |
|
K
|
Koala Company Ltd
ASX:KOA
|
AU |
|
C
|
Chibougamau Independent Mines Inc
OTC:CMAUF
|
CA |
|
JD Health International Inc
F:8ZN
|
CN |
|
D
|
Domino's Pizza Enterprises Ltd
F:HQX
|
AU |
|
Lintes Technology Co Ltd
TWSE:6715
|
TW |
|
Marco Polo Marine Ltd
SGX:5LY
|
SG |
|
Teleperformance SE
OTC:TLPFF
|
FR |
|
S
|
Signet Jewelers Ltd
F:SZ2
|
BM |
|
A
|
ASM International NV
DUS:AVS
|
NL |
|
Coppermoly Ltd
ASX:COY
|
AU |
|
S
|
Sixt SE
XHAN:SIX3
|
DE |
|
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
BR |
|
S
|
Sonic Healthcare Ltd
F:SAB
|
AU |
|
S
|
Song Da No5 JSC
VN:SD5
|
VN |
|
S
|
Sixt SE
SWB:SIX2
|
DE |
|
E
|
Eutelsat Communications SA
F:E3B
|
FR |
|
Sats ASA
F:2S0
|
NO |
Wall St Price Targets
H5P Price Targets Summary
Hikma Pharmaceuticals PLC
According to Wall Street analysts, the average 1-year price target for H5P is 22.53 EUR with a low forecast of 18.45 EUR and a high forecast of 26.25 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is H5P's stock price target?
Price Target
22.53
EUR
According to Wall Street analysts, the average 1-year price target for H5P is 22.53 EUR with a low forecast of 18.45 EUR and a high forecast of 26.25 EUR.
What is the Revenue forecast for Hikma Pharmaceuticals PLC?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for Hikma Pharmaceuticals PLC?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 5 years is 5%.
What is the Operating Income forecast for Hikma Pharmaceuticals PLC?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 8 years is 4%.
What is the Pre-Tax Income forecast for Hikma Pharmaceuticals PLC?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for Hikma Pharmaceuticals PLC?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 5 years is 9%.